文献速递造血干细胞移植与细胞治疗

造血干细胞移植后cGVHD对生存影响统计方法的评价

[Methodological appraisal of statistical approaches to evaluating the impact of chronic graft-versus-host disease on mortality after hematopoietic stem cell transplantation].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2025-01-01

该研究以CIBMTR GV18-03研究中4361例年龄≥40岁、接受HLA 8/8同胞全相合移植的急性髓系白血病或骨髓增生异常综合征患者为例,介绍并比较了处理时间依赖性事件的5种生存分析方法。不同方法在偏倚控制、建模灵活性和临床解释性方面存在显著差异,研究者应根据具体研究目标选择适当方法。

要点

  • 将cGVHD作为基线固定变量易导致未亡时间偏倚。
  • 时间依赖性协变量法可部分校正偏倚,但面临非随机删失和估计不稳定问题。
  • 多状态模型和参数g-formula法能更灵活处理时间依赖性事件与混杂。

核心结论

  • 研究者应结合具体研究目标选用适当方法,确保对时间依赖性事件影响的估计兼具统计学有效性与临床解释合理性。

研究设计与样本

  • 基于国际血液和骨髓移植研究中心GV18-03研究,纳入2008至2017年间年龄≥40岁、接受HLA 8/8同胞全相合移植的急性髓系白血病或骨髓增生异常综合征患者4361例。
  • 分别采用5种统计方法分析cGVHD对总生存率的影响:基线固定变量、时间依赖性协变量、界标分析、多状态模型和参数g-formula法。

主要发现

  • 方法1易导致未亡时间偏倚。
  • 方法2能在一定程度上校正偏倚,但面临非随机删失及前期cGVHD组样本量不足导致估计不稳定的问题。
  • 方法3简明直观,但依赖人为提前设定的界标时点,且无法处理界标时间后才发生的cGVHD。
  • 方法4适用于临床状态动态转移过程的模型构建,能全面描述时间依赖性事件对生存预后的影响。
  • 方法5可同时处理时间依赖性事件与时间依赖性混杂,适合估计特定暴露策略的群体效应。

临床怎么用

  • 研究者应根据研究目标选择统计方法,以确保对时间依赖性事件影响的估计具备统计学有效性与临床解释合理性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: Using the impact of chronic graft-versus-host disease (cGVHD) on overall survival after hematopoietic stem cell transplantation as an example, this study aims to introduces and critically appraises five statistical approaches for handling time-dependent events in survival analysis. Methods: This study was based on data from the Center for International Blood and Marrow Transplant Research (CIBMTR) GV18-03 study. A total of 4361 patients with acute myeloid leukemia or myelodysplastic syndrome were included, who were aged ≥40 years and had received an HLA 8/8 matched sibling donor transplant between 2008 and 2017. Five analytical approaches were used, treating cGVHD as: ① a baseline fixed covariate, ② a time-dependent covariate, ③ a time-dependent event via landmarking analysis, ④ a transitional event in a multi-state model, and ⑤ an exposure in the parametric g-formula. For each approach, we presented its core concept and results, and elaborated on its rationale, strengths, limitations, and applicable scenarios. Results: The five approaches showed significant differences in bias control, modeling flexibility, and clinical interpretability. Method 1 was prone to immortal time bias. Method 2 partially corrected this bias but was vulnerable to informative censoring and estimation instability due to insufficient sample sizes in the early-onset cGVHD group. Method 3 was straightforward but dependent on a predefined landmark time point and unable to account for cGVHD occurring after this point. Method 4 allowed for a comprehensive description of the impact of time-dependent events on survival prognosis by modeling dynamic clinical transitions. Method 5 could simultaneously handle both time-dependent events and confounders, making it suitable for estimating population-level effects of specific exposure strategies. Conclusion: Researchers should select the appropriate method based on their specific study objectives to ensure that the estimation of the impact of time-dependent events on outcomes is both statistically valid and clinically meaningful. 目的: 以造血干细胞移植后慢性移植物抗宿主病(chronic graft-versus-host disease,cGVHD)对总生存率的影响为示例,介绍和辨析生存分析中处理时间依赖性事件的5种常用方法。 方法: 基于国际血液和骨髓移植研究中心(CIBMTR)GV18-03研究,纳入2008至2017年间资料完整、年龄≥40岁、接受HLA 8/8同胞全相合移植的急性髓系白血病或骨髓增生异常综合征患者4 361例。分别将cGHVD作为基线固定变量(方法1)、作为时间依赖性协变量(方法2)、通过界标时间划分(方法3)、考虑为多状态模型(方法4)、应用参数g-formula法(方法5)进行分析。展示每种方法的核心思路和对应的分析结果,阐述方法的原理、优劣与适用情境。 结果: 不同方法在偏倚控制、建模灵活性及临床解释性方面存在显著差异。方法1易导致未亡时间偏倚;方法2能在一定程度上校正偏倚,但面临非随机删失及前期cGVHD组样本量不足,导致估计不稳定的问题;方法3简明直观,但依赖人为提前设定的界标时点,且无法处理界标时间后才发生的cGVHD;方法4适用于临床状态动态转移过程的模型构建,能全面描述时间依赖性事件对生存预后的影响;方法5可同时处理时间依赖性事件与时间依赖性混杂,适合估计特定"暴露策略"(特定时间依赖性事件发生模式)的群体效应。 结论: 研究者应结合具体研究目标,选用适当方法,确保对时间依赖性事件对结局的影响的估计具备统计学有效性与临床解释的合理性。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wu JJ, Wang JF. [Methodological appraisal of statistical approaches to evaluating the impact of chronic graft-versus-host disease on mortality after hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2025. PMID: 41339043. doi:10.3760/cma.j.cn121090-20250731-00356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。